In addition to germline variants, somatic ATM alterations commonly occur in a number of sporadic human cancers, in particular leukemias and carcinomas of the breast and lung [146], and these findings generate new opportunities for the future treatment of these tumors. The gene discussed is ATM; the disease is cancer.